Bone marrow cytoplasmic deoxyribonucleic acid polymerase. Variation of pH and ionic environment as a possible control mechanism.
D000641:Ammonia / Q000494:pharmacology; D000645:Ammonium Sulfate / Q000494:pharmacology; D000818:Animals; D000963:Antimetabolites / Q000494:pharmacology; D001853:Bone Marrow / Q000187:drug effects / Q000201:enzymology*; D001854:Bone Marrow Cells; D002499:Centrifugation, Density Gradient; D002848:Chromatography, DEAE-Cellulose; D002852:Chromatography, Ion Exchange; D003600:Cytosol / Q000187:drug effects / Q000201:enzymology; D004254:DNA Nucleotidyltransferases / Q000302:isolation & purification / Q000378:metabolism*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D006965:Hyperplasia / Q000139:chemically induced / Q000201:enzymology; D008274:Magnesium / Q000494:pharmacology; D008345:Manganese / Q000494:pharmacology; D010659:Phenylhydrazines; D011188:Potassium / Q000494:pharmacology; D011817:Rabbits; D012964:Sodium / Q000494:pharmacology; D014316:Tritium
D000963:Antimetabolites; D010659:Phenylhydrazines; D014316:Tritium; D008345:Manganese; D000641:Ammonia; D012964:Sodium; D004254:DNA Nucleotidyltransferases; D008274:Magnesium; D011188:Potassium; D000645:Ammonium Sulfate